Institute of Biomedical Research Corp.
MRES · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $99 | $5 | – |
| Short-Term Investments | $0 | $0 | $0 | – |
| Receivables | $36 | $36 | $68 | – |
| Inventory | $19 | $30 | $5 | – |
| Other Curr. Assets | $0 | $0 | $0 | – |
| Total Curr. Assets | $108 | $323 | $217 | – |
| Property Plant & Equip (Net) | $6 | $11 | $15 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $3,188 | $3,188 | $18 | – |
| Long-Term Investments | $12 | -$69 | $192 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $0 | $34 | $197 | – |
| Total NC Assets | $3,205 | $3,164 | $421 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $3,314 | $3,488 | $638 | – |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | – |
| Short-Term Debt | $0 | $0 | $0 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $0 | $0 | $0 | – |
| Other Curr. Liab. | $683 | $935 | $283 | – |
| Total Curr. Liab. | $683 | $935 | $283 | – |
| LT Debt | $0 | $0 | $0 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $0 | $0 | $0 | – |
| Other NC Liab. | $93 | $0 | $476 | – |
| Total NC Liab. | $93 | $0 | $476 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $776 | $935 | $759 | – |
| Equity | – | – | – | – |
| Pref Stock | $37 | $37 | $37 | – |
| Common Stock | $2,664 | $2,371 | $1,455 | – |
| Retained Earnings | -$59,056 | -$57,664 | -$58,994 | – |
| AOCI | $0 | $0 | $0 | – |
| Other Equity | $0 | $0 | $0 | – |
| Total Equity | $584 | $1,484 | -$121 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,954 | $1,069 | $0 | – |
| Total Liab. & Tot. Equity | $3,314 | $3,488 | $638 | – |
| Net Debt | -$12 | -$99 | -$5 | $0 |